Non-Steroidal Anti-Inflammatory Drugs Market By Type (paracetamol, Ibuprofen, aspirin, naproxen, and others), By disease indication (Arthritis, Migraine, ophthalmic and others), By Route of administration (Oral and Parenteral), By Application (Hospital Pharmacy, Retail pharmacy and Online Pharmacy) and By Region - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI469021 | Publish Date: August 2023 | No. of Pages: 168

Global Non Steroidal Anti Inflammatory Drugs Market Companies

  • Johnson a d Johnson services
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH,
  • AstraZeneca
  • Bayer AG
  • Horizon Therapeutics plc
  • Zyla Life Sciences
  • Others

Recent News:

  • In May 2022, Dr. Reddy's Laboratories launched Ketorolac Tromethamine Tablets USP, 10 mg. This product is a nonsteroidal anti-inflammatory drug (NSAID) recommended for short-term control of moderate-intensity acute pain, providing opioid-phase pain relief and for use only as continuing treatment after injection. ketorolac tromethamine administered intravenously or intramuscularly, if necessary.
  • , in May 2021, Ono Pharmaceutical Co., Ltd. launched JOYCLU 30 mg intra-articular injection,  Seikagaku received manufacturing and marketing approval in Japan in March 2021.